ArticleAnalytical chemistry2026
CellMate─A Deep Learning-Assisted Single-Cell Data Processing Platform.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mass spectrometry-based single-cell metabolomics (SCM) reveals the inherent heterogeneity of individual cells among seemingly identical cell types. Fast-scanning and high-resolving mass analyzers provide the sensitivity and specificity required to probe minuscule amounts of biological material. However, acquiring data from hundreds of individual cells to achieve statistical power results in complex data sets. This challenge is compounded by the limited availability of specialized data analysis tools for single-cell metabolomics, as many techniques depend on the use of specialized sampling and ionization probes. This results in incompatibility with conventional metabolomics data processing tools. Here, we present CellMate, a MATLAB-based data processing platform designed for single-cell metabolomics using direct infusion techniques. CellMate comprises identification and peak alignment of detected metabolites in an intuitive graphical user interface. CellMate supports customizable quantitative, targeted, and nontargeted metabolomic workflows. The untargeted workflow is enabled by a novel deep learning-based image classification algorithm that effectively distinguishes endogenous metabolites from background species. The source code, along with a compiled installer, is available at github.com /LanekoffLab/CellMate. We believe that CellMate represents a significant advancement in the single-cell metabolomics toolbox, enabling comprehensive data extraction of precious metabolite information from single cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.